IDSA GUIDELINES Bundle (free trial)

Primary Care Guidance for Persons With HIV - 2021

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1414592

Contents of this Issue

Navigation

Page 5 of 33

6 Diagnosis Measles, Mumps, and Rubella 31. All persons with HIV born in 1957 or after should be tested for immunity to measles, mumps, and rubella (MMR) by measuring antibodies. 32. MMR vaccine should be given to protect against measles, mumps, and rubella if persons were born in 1957 or after and have not received this vaccine or do not have immunity to these infections. Varicella Zoster Virus 33. Serologic screening for varicella zoster virus (VZV) may be considered for persons who have not had chickenpox or shingles and who have not been previously vaccinated. (See Section III) Tests That May Be Performed Under Certain Circumstances Chest Radiography 34. A baseline chest radiograph should be obtained in all persons with HIV who have a positive tuberculosis screening test result to rule out active tuberculosis. It may also be useful in other patients who are likely to have preexisting lung abnormalities. Cervical Cancer Screening 35. Persons with a uterus who are <30 years old should have a cervical Papanicolaou (Pap) test performed within one year of the onset of sexual activity but not later than 21 years of age. Persons with HIV between 21–29 years who have a uterus should have a cervical Pap test at diagnosis, if not performed within the last year. Routine human papillomavirus (HPV) testing is NOT recommended for women with HIV <30 years of age, unless Pap test is abnormal. 36. Persons with a uterus who are >30 years old should have a cervical Pap test performed at diagnosis. A Pap test alone or in combination with HPV testing can be performed. 37. Persons with atypical squamous cells of unknown significance (ASC- US) on cytology or negative cytology with positive high-risk HPV (HRHPV) may have the Pap smear repeated in one year or should undergo colposcopy. If the Pap test shows negative cytology but HRHPV 16 or 18, atypical squamous cells and cannot rule out high- grade squamous intraepithelial lesion (ASC-H), atypical glandular cells, low-grade or high-grade squamous intraepithelial lesion, or squamous carcinoma noted by Pap testing, the patient should undergo colposcopy and directed biopsy, with further treatment as indicated by results of evaluation.

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Primary Care Guidance for Persons With HIV - 2021